Pamela Esposito, Director at Kymera Therapeutics, Inc. (KYMR), sold 10,400 shares at $66.68 ($707K) on 2026-01-20, disclosed to the SEC on 2026-01-20.
Open-market sale of $707k KYMR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.68 | 400 | $27K | 3.8% |
| 2 | $67.99 | 4,900 | $333K | 47.1% |
| 3 | $67.99 | 4,900 | $333K | 47.1% |
| 4 | $68.52 | 200 | $14K | 1.9% |
| Total | $67.95 avg | 10,400 | $707K | 100% |
| Filing → |
| KYMR | SELL | 2025-12-17 | $4.4M | — | Filing → |
| KYMR | SELL | 2025-06-03 | $245K | — | Filing → |
| KYMR | SELL | 2024-12-02 | $123K | — | Filing → |